These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37586132)

  • 1. Design, synthesis and evaluation of
    Kumar Sharma A; Sharma R; Dev Sarma H; Mukherjee A; Das T; Satpati D
    Bioorg Chem; 2023 Nov; 140():106761. PubMed ID: 37586132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and
    Sharma AK; Sharma R; Das A; Chakraborty A; Rakshit S; Sarma HD; Mukherjee A; Das T; Satpati D
    Bioconjug Chem; 2023 Sep; 34(9):1576-1584. PubMed ID: 37379455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and comparative evaluation of
    Sharma AK; Sharma R; Vats K; Sarma HD; Mukherjee A; Das T; Satpati D
    Sci Rep; 2022 Sep; 12(1):15720. PubMed ID: 36127494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting HER2-receptors with
    Kumar Sharma A; Satpati D; Sharma R; Das A; Dev Sarma H; Mukherjee A
    Bioorg Chem; 2023 Jun; 135():106503. PubMed ID: 37037128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
    Gu J; Chen X; Fang X; Sha X
    Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction.
    Li C; Zhan C; Zhao L; Chen X; Lu WY; Lu W
    Bioorg Med Chem; 2013 Jul; 21(14):4045-50. PubMed ID: 23660015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. Specificity and kinetic rate-constant measurements.
    Benkirane N; Guichard G; Van Regenmortel MH; Briand JP; Muller S
    J Biol Chem; 1995 May; 270(20):11921-6. PubMed ID: 7744843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sequence and stereochemistry reversal on p53 peptide mimicry.
    Atzori A; Baker AE; Chiu M; Bryce RA; Bonnet P
    PLoS One; 2013; 8(7):e68723. PubMed ID: 23922660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics.
    Guichard G; Benkirane N; Zeder-Lutz G; van Regenmortel MH; Briand JP; Muller S
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9765-9. PubMed ID: 7937888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of retro-inverso peptides as synthetic vaccines.
    Muller S; Benkirane N; Guichard G; Van Regenmortel MH; Brown F
    Expert Opin Investig Drugs; 1998 Sep; 7(9):1429-38. PubMed ID: 15992041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides.
    Liu Y; Mei L; Yu Q; Zhang Q; Gao H; Zhang Z; He Q
    Amino Acids; 2015 Dec; 47(12):2533-9. PubMed ID: 26173509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.
    Osl T; Schmidt A; Schwaiger M; Schottelius M; Wester HJ
    Theranostics; 2020; 10(18):8264-8280. PubMed ID: 32724470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
    Jones S; Howl J
    Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the solution conformations of a human immunodeficiency virus peptidomimetic and its retro-inverso isomer using 1H NMR spectroscopy.
    Higgins KA; Bicknell W; Keah HH; Hearn MT
    J Pept Res; 1997 Dec; 50(6):421-35. PubMed ID: 9440043
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Rezazadeh F; Sadeghzadeh N; Abedi SM; Abediankenari S
    Nucl Med Biol; 2018; 62-63():54-62. PubMed ID: 29885559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The partial retro-inverso modification: a road traveled together.
    Chorev M
    Biopolymers; 2005; 80(2-3):67-84. PubMed ID: 15729688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
    Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
    Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
    Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, preparation and biological evaluation of a
    Behnammanesh H; Jokar S; Erfani M; Geramifar P; Sabzevari O; Amini M; Mazidi SM; Hajiramezanali M; Beiki D
    Bioorg Chem; 2020 Jan; 94():103381. PubMed ID: 31662215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification.
    Verdini AS; Silvestri S; Becherucci C; Longobardi MG; Parente L; Peppoloni S; Perretti M; Pileri P; Pinori M; Viscomi GC
    J Med Chem; 1991 Dec; 34(12):3372-9. PubMed ID: 1766001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.